Trial Profile
Phase II trial of tretinoin (ATRA) in combination with the antidepressant, tranylcypromine, for the treatment of acute myeloid leukaemia.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tranylcypromine (Primary) ; Tretinoin (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms TCP-AML
- 29 Mar 2018 Status changed from recruiting to completed.
- 27 Mar 2012 New trial record